The tyrosine phosphorylation of secretion machinery proteins is a crucial regulatory 42 mechanism for exocytosis. However, the participation of tyrosine phosphatases in 43 different exocytosis stages has not been defined. Here, we demonstrated that PTP-MEG2 44 controls multiple steps of catecholamine secretion. Biochemical and crystallographic 45 analysis revealed key residues that govern the PTP-MEG2 and NSF-pY 83 site interactions, 46 specify PTP-MEG2 substrate selectivity and modulate the fusion of catecholamine-47 containing vesicles. Unexpectedly, delineation of the PTP-MEG2 mutants along with the 48 NSF interface revealed that PTP-MEG2 controls the fusion pore opening through another 49 unknown substrate. Utilizing a bioinformatics search and biochemical and 50 electrochemical screening, we uncovered that PTP-MEG2 regulates the opening and 51 extension of the fusion pore by dephosphorylating the MUNC18-1 Y 145 site, which is 52 associated with epileptic encephalopathy. The crystal structure of the PTP-53
INTRODUCTION 76 77
Secretion via vesicle exocytosis is a fundamental biological event involved in almost all 78 catecholamine secretion from adrenal glands, we therefore applied our newly developed 140 specific PTP-MEG2 inhibitor (Compound 7) (Supplemental Fig. 1-1C ). The inhibitor 141
Compound 7 is a potent PTP-MEG2 inhibitor, with a potency of 34 nM and extraordinary 142 selectivity against other phosphatases (Zhang et al., 2012) . The administration of either high 143 concentrations of potassium chloride (70 mM) or 100 nM Angiotensin II (AngII) significantly 144 increased the secretion of both epinephrine (EPI) and norepinephrine (NE) from adrenal 145 medulla, as previously reported (Liu et al., 2017, Teschemacher and Seward, 2000) , and this 146 effect was specifically blocked by pre-incubation with Compound 7 (2 μM) for 1 hour (Fig. 147 1A-D). Notably, basal catecholamine secretion was also decreased after pre-incubation with 148
Compound 7 ( Fig. 1A-D) . However, the catecholamine contents were not changed in response 149 to Compound 7 incubation (Supplemental Fig. 1-1D -E). These results indicated that MEG2 plays an essential role in catecholamine secretion from the adrenal medulla. Angiotensin II-induced catecholamine secretion was gradually attenuated by increasing the 159 concentration of Compound 7 after pre-incubation with the primary chromaffin cells, from 20% 160 at 100 nM Compound 7 to 80% at 2 μM inhibitor ( Fig. 1E -F and Supplemental Fig. 1-1 F-H) . 161 We then compared isolated amperometric spikes of chromaffin cells pre-incubated with 162 different concentrations of Compound 7 to determine the effect of the inhibition of PTP-MEG2 163 activity on quantal size (total amperometric spike charge) and vesicle release probability. The 164 application of PTP-MEG2 inhibitor reduced quantal size, as indicated by statistical analysis of 165 the quantal size distribution and averaged amperometric spike amplitude ( Fig. 1G and 166 Supplemental Fig. 1-1 I) . Specifically, the peak of the amperometric spikes was reduced from 167 1.1 pC to 0.5 pC after incubation with 400 nM Compound 7 (Fig. 1G ). The number of induced amperometric spikes was also significantly decreased in the presence of Compound 7, 169 suggesting that either the release probabilities of individual vesicles or the size of the readily 170 released pool was affected (Supplemental Fig. 1-1 J) . to their distance from the chromaffin plasma membrane (Fig. 1J ). However, the application of 177 400 nM Compound 7 significantly decreased the number of docking vesicles in contact with 178 the plasma membrane ( Fig. 1K-L) . These results indicated that the inhibition of PTP-MEG2 179 activity by Compound 7 decreased the release probabilities of individual vesicles but did not 180 affect the size of the readily released pool. Moreover, the observed numbers of LDCVs with 181 diameters larger than 150 nm observed by electron microscopy were significantly decreased by 182 more than 70% after incubation with Compound 7 (Fig. 1M) , which is consistent with the 183 statistical analysis of the total amperometric spike charge obtained by electrochemical 184 measurement (Supplemental Fig. 1-1H-M) . Generally, the presence of pre-spike foot (PSF) is a common phenomenon preceding large 189 amperometric spikes of catecholamine secretion in chromaffin cells, while stand-alone foot 190 (SAF) is considered to represent "kiss-and-run" exocytosis (Chen et al., 2005) . Both PSF and 191 SAF are generally considered indications of the initial opening of the fusion pore (Alvarez de 192 Toledo et al., 1993 , Zhou et al., 1996 . In this study, the PSF frequency significantly decreased 193 from 25% to 3% after pre-incubation with Compound 7 in response to AngII stimulation (Fig. 194 1N). The inhibitor Compound 7 had no significant effect on the PSF duration (Supplemental 195 Fig. 1 -2 C-D) but markedly reduced the amplitude and charge of PSF (Supplemental Fig. 1-2 196 E-F). Similar results were observed for the SAF (Supplemental Fig. 1 -2 G-J). The inhibitor Compound 7 reduced the SAF percentage from 18% to 4% (Fig. 1N) . Intriguingly, the 198 duration of SAF was also decreased with increasing Compound 7 concentration, in contrast to 199 and carbonyl groups of pY 83 and T 84 . C-terminal to NSF-pY 83 , Q 559 forms a van der Waals 261 interaction with T 84 , and F 85 forms substantial hydrophobic interactions with V 336 , F 556 and I 519 262 (Fig. 3A) . Accordingly, mutation of D 335 A or Q 559 A showed no significant effect on pNPP 263 activity but substantially decreased their activities towards the phospho-NSF peptide ( Fig. 3B -264 C and Supplemental Fig. 3A-B ). Mutation of I 519 A caused a decrease in the intrinsic activity of 265 PTP-MEG2 and a further decrease of approximately 4-fold in its ability to dephosphorylate 266 phospho-NSF-peptide. Moreover, Y 471 forms extensive hydrophobic interactions with T 84 and 267 Y 85 and a hydrogen bond with the carboxyl group of pY 83 . Mutation of Y 471 to either A or F 268 greatly reduced its activity towards phospho-NSF-E 79 -pY 83 -K 87 peptide but had little effect on 269 pNPP dephosphorylation. Taken together, the structural analysis and enzymology studies 270 identified G 334 , D 335 , Y 471 , I 519 and Q 559 as critical residues for the substrate recognition of NSF 271 by PTP-MEG2. Importantly, although none of these residues are unique to PTP-MEG2, the 272 combination of these residues is not identical across the PTP superfamily but is conserved 273 between PTP-MEG2 across different species, highlighting the important roles of these residues 274 in mediating specific PTP-MEG2 functions ( to D 335 :Q 559 of PTP-MEG2 determining the entrance of the pY+1 residue into the pY+1 pocket, 286 such as PTP1B, LYP, PTPN18, STEP, PTP-Meg1, SHP1, PTPH1 and SHP2, structural analysis 287 indicated that the Cβ between Q 559 and D 335 is the smallest in PTP-MEG2, at least 1 Å narrower 288 than in the other PTP structures examined (Fig. 4B ). The narrower pY+1 pocket entrance could 289 be a unique feature of the substrate recognition of PTP-MEG2. We next infected primary chromaffin cells with lentivirus encoding wild-type PTP-MEG2 296 or different mutants for electrochemical investigation of the structure-function relationship of 297 PTP-MEG2 in the regulation of catecholamine secretion ( Fig. 5A and Supplemental Fig. 5A -298 F). In addition to wild-type PTP-MEG2, we chose 5 PTP-MEG2 mutants, including G 334 R, 299 D 335 A, Y 471 A, Y 471 F, I 519 A and Q 559 A, whose positions are determinants of the interactions 300 between PTP-MEG2 and NSF from the pY 83 -1 position to the pY 83 +2 position (Fig. 5B ). The 301 overexpression of wild-type PTP-MEG2 significantly increased both the number and amplitude 302 of the amperometric spikes, which are indicators of the release probabilities of individual 303 vesicles and quantal size, respectively ( Fig. 5C-F Unexpectedly, the PTP-MEG2 mutants showed different effects on the probability of the 311 occurrence of the foot, which is an indicator of the initial opening of the fusion core ( Fig. 5G ). 312 G 334 R mutation which disrupted the recognition of the N-terminal conformation of the peptide 313 substrate of PTP-MEG2, and D 335 A and Q 559 A, which are the determinants of pY+1 substrate 314 specificity, significantly reduced the high potassium chloride-induced foot probability. The 315 mutations of I 519 and Y 471 , which form specific interactions with the F 85 of the NSF and are 316 determinants of the C-terminal region of the central phospho-tyrosine involved in the substrate 317 specificity of PTP-MEG2, showed no significant effect ( Fig. 5B and Fig. 5G ). These results 318 indicated that PTP-MEG2 regulated the initial opening of the fusion core via a distinct structural 319 basis from that of vesicle fusion, probably through dephosphorylating other unknown substrates. 320
As D 335 A and Q 559 A of PTP-MEG2 maintained the occurrence of the foot probability, the 321 unknown PTP-MEG2 substrate that regulates the fusion pore opening should have a small 322 residue, such as G, A, S or T at the pY+1 position. Conversely, the unknown PTP-MEG2 323 substrate should have a less hydrophobic residue at the pY+2 position because Y 471 F, Y 471 A and 324 I 519 A of PTP-MEG2 had no significant effect on the foot probability. The effects of PTP-MEG2 mutations along the PTP-MEG2/NSF-phospho-segment 330 interface on catecholamine secretion indicated that not NSF but another PTP-MEG2 substrate 331 with distinct sequence characteristics contributes to the regulation of "foot probability" (Fig. 332 5). We therefore utilize this key information to search for new potential PTP-MEG2 substrates 333 by bioinformatics methods (Fig. 6A ). First, we searched for the keywords "fusion pore", 334 "secretory vesicle" and "tyrosine phosphorylation" using the functional protein association 335 network STRING and the text mining tool PubTator, which resulted in a candidate list of 55 336 proteins. Second, we applied UniProt by selecting proteins located only in the membrane or 337 vesicle, which limited the candidates to 28 members. Third, as our experiments were carried 338 out in the adrenal gland, we used the Human Protein Atlas database for filtering, which 339 narrowed the candidate list to 18 proteins. Finally, we exploited the post-translational-motif 340 database PhosphoSitePlus to screen candidate proteins with potential phospho-sites that 341 matched the sequence requirements at both the pY+1 position and the pY+2 position, which 342 are "G, S, A, T, V, P" and "G, A, S, T, C, V, L, P, D, H", respectively. These positions were 343 further evaluated by surface exposure if a structure was available. The combination of these 344 searches produced 11 candidate lists with predicted pY positions ( Fig. 6B ). carbonyl oxygens of I 539 and G 568 (Fig. 7B ). These key interactions might be involved in 372 regulating the arrangement of the arc shape of the three domains of MUNC18-1. The 373 phosphorylation of Y 145 likely abolishes this H-bond network and changes its ability to associate 374 with different snare complexes participating in vesicle fusion procedures ( Fig. 7B) . 375 Interestingly, a missense mutation of MUNC18-1 Y 145 H was found to be associated with early 376 infantile epileptic encephalopathy (Stamberger et al., 2017) ( Fig. 7C) . 377
378
Notably, the Y 145 H missense mutation may not be phosphorylated properly. We therefore 379 overexpressed wild-type MUNC18-1, Y 145 A, a non-phosphorylable mutant, and the disease- To further dissect the mechanism underlying the phosphorylation of MUNC18-1 Y 145 as 400 well as the disease-related mutant Y 145 H in the regulation of hormone secretion, we compared 401 the interactions of wild-type and mutant MUNC18-1 with the binding partner SYNTAXIN1 402 (Lim et al., 2013) . Importantly, both the phosphorylation mimic mutant MUNC18-1-Y 145 E and 403 the disease-related mutant Y 145 H significantly impaired the interaction between MUNC18-1 404 and SYNTAXIN1 (Fig. 7G ). These results suggested that the phosphorylation of Y 145 of 405 MUNC18-1 decreases the binding of MUNC18-1 to SYNTAXIN1, which plays an important 406 role in the formation of the foot during catecholamine secretion. In contrast, the 407 dephosphorylation of pY 145 of MUNC18-1 by PTP-MEG2 promoted initial pore opening and 408 fusion. 409 410
Structural basis of the PTP-MEG2-MUNC18-1 interaction 411
The kcat/Km of PTP-MEG2 towards a phospho-segment derived from MUNC18-1-pY 145 is 412 very similar to that obtained with a phospho-segment derived from the known substrate pY 83 413 site of NSF (Supplemental Fig. 3A-B and 8A). We therefore crystallized the PTP-MEG2 414 trapping mutant with the MUNC18-1-E 141 -pY 145 -S 149 phospho-segment and determined the 415 complex structure at 2.2 Å resolution ( Table 1) specificity of the pY+1 site, but also provided clues that PTP-MEG2 regulated the initial 464 opening of the fusion pore through another unknown substrate. Fortunately, we were able to 465 deduce the signature of the pY+1 and pY+2 positions of this unknown substrate by carefully 466 inspecting the PTP-MEG2/phospho-NSF-E 79 -pY 83 -K 87 complex structure and analysing the 467 functional data of the PTP-MEG2 interface mutants. Further bioinformatics studies and cellular 468 and physiological experiments enabled us to discover that PTP-MEG2 regulates the initial 469 opening of the fusion pore by modulating the tyrosine phosphorylation states of MUNC18-1 at 470 the pY 145 site. Therefore, we have revealed that PTP-MEG2 regulates different steps of the 471 exocytosis processes via distinct substrates. PTP-MEG2 regulates the vesicle size and vesicle-472 vesicle fusion step by dephosphorylating NSF at its NSF-pY 83 site, whereas it regulates the 473 process of large-dense-core vesicle fusion pore initiation and expansion by controlling 474
MUNC18-1 at the pY 145 site. Moreover, our studies highlight that the combination of structural 475 determination and functional delineation of the interface mutants of the protein complex is a 476 powerful approach to characterizing the signalling events and identifying unknown downstream 477 signalling molecules. 478
Fusion pore opening and expansion is thought to be a complex process requiring the 479 docking of apposed lipid bilayers and involvement of multiple proteins to form a hemi-fusion physiological relevance in exocytosis is not evaluated, and the endogenous modulator is not 497 accurately defined. In the present study, we demonstrated that the MUNC18-1 Y 145 E phospho-498 mimic mutation, but not the non-phosphorylated mutation Y 145 F, significantly decreased the 499 PSF and the SAF probability. Consistently, only the specific PTP-MEG2 mutations that affect 500 its activity towards MUNC18-1 reduced the PSF probability. The structural analysis of PTP-501 MEG2 in complex with MUNC18-1-pY 145 and the enzymatic analysis further confirmed these 502 observations. Collectively, these results indicate that the tyrosine phosphorylation of MUNC18-503 1 at its Y 145 site and its dephosphorylation by PTP-MEG2 play essential roles in the regulation 504 of the fusion pore opening process. Notably, the MUNC18-1 Y 145 H mutation is a known SNP 505 that is associated with epileptic encephalopathy (Stamberger et al., 2017). Y 145 H behaves 506 similarly to the MUNC18-1 phosphorylation mimic mutant Y 145 E by disrupting its interaction 507 with SYNTAXIN1 and reducing the probability of PSF elicited by AngII in primary chromaffin 508 cells. This observation provided a clue for the pathological effects of the MUNC18-1 Y 145 H 509 mutation. In addition to MUNC18-1, we found that VAMP7 interacted with PTP-MEG2 via its 510 Y 45 tyrosine phosphorylation site. DYNAMIN-1, PASCIN1 and SNAP25 are also potential 511 PTP-MEG2 substrates depending on specific cellular contexts. The functions of VAMP7 512 phosphorylation at the Y 45 site and its dephosphorylation by PTP-MEG2, the interaction of 513 PTP-MEG2 with DYNAMIN-1, etc. in the exocytosis process await further investigation. 514
Finally, by solving the two crystal structures of PTP-MEG2 in complex with two substrates, 515 the phospho-NSF-E 79 -pY 83 -K 87 segment and the phospho-MUNC18-1-E 141 -pY 145 -S 149 segment, 516
we revealed that PTP-MEG2 recognized these functionally different substrates through distinct 517 structural bases. Whereas K 411 , Y 471 and I 519 contributed most to the selective interaction of 518 PTP-MEG2 with NSF, another set of residues, including V 393 and R 410 , mediated the specific 519 binding of PTP-MEG2 to MUNC18-1 ( Fig. 8B ). Most importantly, mutating Y 471 and I 519 to A 520 significantly decreased the activity of PTP-MEG2 towards the phospho-NSF-E 79 -pY 83 -K 87 521 segment but not the phospho-MUNC18-1-E 141 -pY 145 -S 149 segment. The biochemical data 522 agreed well with the functional data that PTP-MEG2 Y 471 A and I 519 A of PTP-MEG2 affected 523 only the vesicle fusion procedure but not the fusion pore opening and expansion processes. 524
These data not only indicate that PTP-MEG2 regulates different steps of exocytosis through 525 different substrates in an explicit temporal and spatial context but also afforded important 526 guidance for the design of selective PTP-MEG2 inhibitors according to the different interfaces 527 between PTP-MEG2 and its substrates to explicitly regulate specific physiological processes, 528 supporting the hypothesis of "substrate-specific PTP inhibitors" (Doody and Bottini, 2014). 529
The design of such inhibitors will certainly help to delineate specific roles of PTP-MEG2 in 530 different physiological and pathological processes. 531
In conclusion, we have found that PTP-MEG2 regulates two different processes of 532 exocytosis during catecholamine secretion, namely, vesicle fusion and the opening and 533 extension of the fusion pore, through two different substrates with distinct structural bases. We We thank Dr Michael Xi Zhu for stimulating discussions and critical reading of the manuscript. 546 We thank Dr Zhongliang Zhu of University of Science and Technology of China, for his help 547 in the crystal data collection, analysis and valuable discussion. We thank Yanmei Lu from 548 Shandong jiaotong hospital, for her help with Transmission electron microscopy analysis. We 549 thank Daolai Zhang and Mingliang Ma for their technical assistance in lentivirus packaging. association network STRING and the text mining tool PubTator by searching the keywords 893 "fusion pore", "secretory vesicle" and "tyrosine phosphorylation". These proteins were filtered 894 with UniProt by selecting proteins located only in the membrane or vesicle, which resulted in 895 28 candidates. The Human Protein Atlas database was then applied to exclude proteins with no 896 expression in the adrenal gland. Finally, we used the post-translational-motif database 897
PhosphoSitePlus to screen candidate proteins with potential phospho-sites that matched our 898 sequence motif prediction at the pY+1 or pY+2 positions. 899 (B). After the bioinformatics analysis, a total of 11 candidate PTP-MEG2 substrates that may 900 participate in fusion pore initiation and expansion and their potential phospho-sites were 901 displayed. and different mutations of the FLAG-VAMP7-Y 45 A or Y 45 C mutants 24 hours before 930 stimulation with 100 nM AngII, respectively. The cell lysates were then incubated with GST-931 PTP-MEG2-D 470 A for 4 hours with constant rotation. The potential PTP-MEG2 substrates were 932 pulled down by GST-beads, and their levels were examined by the FLAG antibody with 933 Western blotting. 934 (E). Primary chromaffin cells were transduced with lentivirus containing the gene encoding 935 wild-type MUNC18-1 or different mutants. These cells were stimulated with 100 nM AngII. 936
The amperometric spikes were detected with CFE. Typical amperometric traces are shown. 937 (F). The percentages of pre-spike foot (left) and stand-alone foot (right) for wild-type 938 MUNC18-1 or different mutants were calculated. 939 (G). The MUNC18-1-Y 145 mutation decreased the interaction between MUNC18-1 and 940 SYNTAXIN1. PC12 cells were transfected with plasmid carrying SYNTAXIN-1. The 941 proteins in cell lysates were pulled down with purified GST-MUNC18-1-Y 145 and the GST- residues of NSF and MUNC18-1 are coloured as follows: green, residues interacting with both 957 NSF and MUNC18-1; red, residues strongly contributing to NSF recognition; blue, residues 958 strongly contributing to MUNC18-1 interaction. 959 The HEK293 cell lines, the 293T cell lines and PC12 cell lines were originally obtained from 989 the American Type Culture Collection (ATCC). The HEK293 cell lines and 293T cell lines 990 were grown in DMEM with 10% FBS (Gibco, Grand Island, NY, US) and 1% 991 penicillin/streptomycin at 37 °C. PC12 cells were maintained at 37 °C in DMEM medium 992 containing 10% FBS (Gibco, US), 5% donor equine serum (Gibco, US) and 1% 993 penicillin/streptomycin. 
